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1. Introduction 
The interaction of polyvalent ligands, such as 
antibodies or lectins with cell surface structures of 
living lymphocytes or other cell types, often leads to 
a redistribution of plasma membrane constituents 
into clusters, patches and caps. The redistribution 
process is not fully understood but it is a meta- 
bolically dependent active process, possibly involving 
the activity of contractile microfilaments [l] and 
microtubules [2,6]. It appears likely that receptors 
of the membrane may partially be immobilized by 
cross linkages with the ligands [3]. As a consequence, 
the complexes formed become concentrated in the 
tail position of the cell, as the free membrane com- 
ponents flow forward as a part of the normal 
process of cell movement [4]. However, the inhibi- 
tion of the Con A-induced cocapping of unrelated 
membrane receptors, e.g. by colchicine, points to an 
additional involvement of colchicine-sensitive micro 
structures. Following cap formation, the ligand- 
receptor complexes can be taken up by the cell 
through pinocytosis and/or be shed into the medium 
[S] . It is unclear which of those phenomena may 
perhaps be an important factor for possible triggering 
of the cell [4,6]. Ligand-induced redistribution has 
*Abbreviations: Ganglioside GGtetl = Gal p-+3GalNAcp-L 
4Gal(3ccuNeuAc) p+4Glc-Ceramide PIS 04 = polyionic 
isotonic solution [ 201. DANSyl = 5-dimethylamino- 
naphthalene-1-sulfonyl-. 
272 
been demonstrated with antibodies directed against 
a variety of protein or carbohydrate [7] antigens 
located at the plasma membrane (immunoglobulins, 
8, TL, H-2, HLA) and also for various phytomitogens, 
i.e. lectins (wheat germ phythemagglutinin, concanavalin 
A, pokeweed) and endotoxins, (for review see [l] ). 
Since membrane receptors which undergo capping 
have been envisioned as mobile units consisting of 
single or grouped protein molecules floating and 
diffusing in the plane of a fluid bilayer of lipid, it 
was of interest to see whether lipid also could 
directly take part in the capping phenomenon. 
The glycolipid ganglioside GG,J* which occurs 
localised in the plasma membrane of mammalian cells 
is known to interact strongly and specifically with 
cholera toxin [8,9]. Using fluoresceine-labelled 
cholera toxin, Craig and Cuatrecasas [lo] have 
demonstrated a redistribution and cap formation on 
the surface of lymphocytes which was temperature- 
dependent and sensitive for metabolic inhibitors. This 
observation could be confirmed very recently by 
Revesz and Greaves [ 1 l] , using fluoresceine-conjugat- 
ed antibodies against cholera toxin. However, to prove 
unequivocally the lipid nature of the membrane 
receptor molecules, a more direct approach was 
chosen, using a fluorescent-labelled synthetic sialogly- 
colipid, in short: ‘DANSyl-gangliosidoide’. (fig. 1). 
This lipid could be incorporated into the plasma 
membrane and reacted specifically with cholera toxin. 
After the fluorescent-iabelled sialoglycolipid was 
bound to the cell membrane of lymphocytes, redis- 
tribution of the fluorescence occured and caps were 
formed upon reaction with the cholera toxin. 
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Fig. 1 . DANSyl-fluorescent-labelled cholera toxin-receptor sialqlycolipid (Gal@-+3GalNAcp+Kal (3ccuNeuAc) p+4[ ldesoxy-l- 
N-DANSyl-octadecylamino-] sorbitol (DANSyl-gangliosidoi’de). 
2. Materials and methods 
2.1. Synthesis of DANSyl-gangliosidoii 
Ganglioside GGJ was isolated as described 
earlier [ 121. The free sialo-oligosaccharide moiety of 
this ganglioside was prepared [ 131 and reductaminated 
in the presence of octadecylamine to yield GalC(1+3 
GalNAc/31+4Gal(3+-2aNeuAc) B1-+4[ l-desoxy-l- 
octadecylarnino-sorbitol] [ 141. Following the method 
of Gray [ 151, this sialo-glycolipid was N-DANSylated 
to the DANSyl-gangliosidoi’de shown in fig. 1. The final 
product was purified by preparative thin layer 
chromatography on silica gel (E. Merck) with chloro- 
form:methanol:water (65:35:8) as solvent system. 
The DANSyl-gangliosidoie migrated on silica gel F254 
(Rapid Fertigplatten Woelm) using the above system 
with R= 1.08 relative to ganglioside GGt,tl. 
2.2. Preparation of the lymphocytes 
Lymphocytes were isolated from human peripheral 
blood by preincubation on glass bead columns and 
gradient centrifugation in a modification of Boyum’s 
methods [ 161. A part of the lymphocytes was 
pretreated with 0.25% trypsin for 30 min at 20°C. 
After excessive washings, various concentrations of 
untreated and pretreated lymphocytes in isotonic 
medium (PIS 04) were incubated with various amounts 
of DANSyl-gangliosidoi’de for different time periods 
and at different temperatures. After washing 4 times, 
the cells were either immediately examined micro- 
scopically (viable under cover glass sealed with paraffin 
or dead on a smear) or the cells (sediment with 
2 X lo7 lymphocytes) were resuspended in and 
incubated with 0.1 ml cholera toxin protein I 
(0.1 nmol/ml, with or without cholchicine ( 10-6,mol/ 
ml) for different times at different temperatures. 
Subsequently, the cells were examined microscopi- 
cally in the same way as mentioned above. 
2.3. Microscopical examinations 
A Zeiss photomicroscope was used equipped with 
a HBO 200 light source, a Ploem type vertical 
illuminator and a III RS-condenser with an excita- 
tion filter UGI; reflector F1400 and barrier filter 
41. For fluorescein fluorescence, the excitation filter 
G 455, 2 X KP 500, reflector FL 500 and barrier 
filter 50 were used. All microscopical examinations 
were performed with a magnification of 1250 times. 
2.4. Precipitation of cholera toxin-subunit-protein I 
with DANSyl-gangliosidoide 
Cholera toxin-subunit protein I, equilibrated with 
sodium phosphate buffer, 0.1 M, 0.5 mM EDTA, pH 
7.2, was adjusted to a concentration of 5 nmol/ml 
(MR = 54.000). The DANSyl gangliosidoi’de or ganglio- 
side GGt,tl, both at concentrations of 0.1 pmol/ml of 
the above-mentioned buffer were mixed with aliquots 
of the solution of protein I. Mixtures at molar ratios of 
0.1: 1, 1: 1, 2: 1, and 4: 1 for the glycolipid and protein I 
complexes were prepared. Precipitate formation was 
visually estimated 20 h later and the inhibition of 
immunoprecipitates was evaluated by immunodiffusion 
against antiserum to protein I, essentially as described 
earlier [9] . 
3. Results 
3.1. Interaction of DANSyl-gangliosidoii with 
protein I-subunit of cholera toxin 
The DANSyl-gangliosidoi’de precipitated protein I. 
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Fig.2. Capping of DANSyl-gangliosidoide-treated lymphocyte 
induced by treatment with cholera toxin-subunit protein I.Ig 
receptors of the lymphocyte redistribute into the same cap. 
However, differences in the formation of insoluble 
precipitates with protein I were observed for the 
DANSyl-sialoglycolipid as compared to ganglioside 
Gctetl. The DANSyl-gangliosidoi’de precipitated 
protein I at a molar ratio as low as 1: 1, whereas 
ganglioside G Ctetl protein I complexes became 
insoluble only at a molar ratio of 4: 1. However, as 
can be seen from fig.2, the DANSyl-gangliosidoi’de as 
well as ganglioside GGtetl caused an inhibition of 
immunoprecipitation between protein I and its anti- 
serum at molar ratios higher than 1: 1. This differential 
behaviour is closely related to the observations made 
with gangliosidoi’de and ganglioside cholera toxin 
complexes [9]. 
3.2. Binding of DANSyl-gangliosidoide to the membrane 
of ly mphocy tes 
The incorporation of DANSyl-gangliosidoide into 
the membrane of lymphocytes and granulocytes was 
clearly temperature dependent. Addition of 1 or more 
nmol DANSyl-ganghosidoi’de to 5 X lo6 lymphocytes 
at 37°C resulted in a pronounced surface fluorescence 
of all the lymphocytes or contaminating granulocytes. 
However, the fluorescence intensity was variable. 
Lowering the incubation temperature to 20°C, 4°C or 
0°C led to a significantly reduced fluorescence inten- 
sity and a decreased number of fluorescent-labelled 
lymphocytes. This effect could be observed in 
lymphocytes from all donors examined but appears 
to be quantitatively different between the single 
donors. The temperature dependence of the incorpora- 
tion of DANSyl-ganghosidoi’de points to the fact that 
this glycolipid is incorporated into the lipid bilayer 
proper of the outer cell membrane. 
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3.3. Effect of cholera toxin subunit-protein I on 
lymphocytes labelled with DANSyl-ganglio- 
sidoide (table I) 
Subsequent incubation of DANSyl-gangliosidoi’de- 
treated lymphocytes with cholera toxin protein I- 
subunit caused a time- and temperature-dependent 
redistribution of the membrane bound fluorescence. 
After 10 minutes incubation at 37°C cap formation 
was observed in a few cells. After 20 min of incuba- 
tion, the number of cap forming cell increased 
significantly compared to cells incubated similarly 
at 4”. Caps could be located distinctly in the uropod 
region of the lymphocytes. 
Lymphocytes treated with DANSyl-gangliosidoi’de 
but without any post-treatment of cholera toxin- 
protein I formed caps too. However, the percentage 
of those cap-forming cells was temperature independent 
and was much lower than after treatment with protein 
I at 4°C (table 1). 
3.4. Influence of colchicine 
Addition of colchicine ( low6 M) to the incubation 
medium reduced the number of protein I induced cap 
forming DANSyl-gangliosidoide-treated lymphocytes 
in all cases (table 1). 
3.5. Effect of tlypsin (table 1) 
Pretreatment of lymphocytes with trypsin appears 
to have no effect on the uptake of DANSyl- 
gangliosidoi’de by the membrane of lymphocytes or 
granulocytes, as could be judged from the fluorescence 
intensity of the preparations. However, cap formation 
induced by cholera toxin protein I was markedly 
reduced by a pretreatment of the cells with the pro- 
tease. 
3.6. Cocapping of lymphocyte anti-immunoglobulin 
receptors 
In order to study a possible cocapping of the 
immunoglobulin G receptors present on the surface 
of peripheral lymphocytes, white blood cells treated 
differently in the way described above, were subse- 
quently incubated with fluoresceine-conjugated anti- 
human-Ig polyvalent antibodies of the rabbit (Op-Nr. 
F642, Behring Werke, Marburg) for 30 min at 20°C. 
The presence of Ig-receptors was observed. Ig-recep- 
tors redistributed into caps after DANSyl-gangliosi- 
doi’de pretreatment as well as after additional treat- 
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Table 1 
Cap formation of DANSyl gangliosidoide cholera toxin protein 1 









4°C 1, controlb 2 2 
1 2 1 3 2 
10 11 6 7 2 
37°C 1, controlb 3 3 
1 9 3 6 2 
10 25 11 5 I 
a Concentration of DANSyl gangliosidoide (0.1 ml) per 1 X 10’ lymphocytes (sediment). 
Incubation for 15 min. After 4 washes subsequently, 0.01 nmol cholera toxin protein 
I per 1 X 10’ lymphocytes for 30 min. 
b Control, incubation with 1 X low9 mol/l X 10’ cells/O.1 ml DANSy! gangliosidoide 
but without subsequent incubation with cholera toxin protein I. 
’ Simultaneous incubation with colchicine (1 X lo-’ mol/l X lo7 cells/O.1 ml). 
d Pretreatment of lymphocytes with 0.25% trypsin, 30 min., 20°C. 
ment with cholera toxin protein subunit I. However, 
in the case of glycolipid capping, Ig-receptors always 
moved into the same cell pole as the DANSyl-ganglio- 
sidoide-protein I complex. 
4. Discussion 
The ganglioside-membrane-receptor binding protein 
subunit of cholera toxin, i.e. protein I instead of the 
intact toxin itself, was chosen for this investigation 
in order to avoid any interference arising from an 
activation of the cell’s adenylate cyclase system by 
the toxin subunit protein II [ 171. The synthetic 
gangliosidoi’de which carries a DANSyl-fluorescent 
label, binds to protein I of cholera toxin strongly and 
specifically as it is known for the natural toxin 
receptor, the ganglioside GGtetl. Moreover it could 
be demonstrated that DANSyl-gangliosidoie binds to 
the cell membrane, perhaps in a similar fashion as 
has already been shown for other gangliosides [ 18,191. 
Since the binding is temperature dependent, it can 
be argued that the incorporation of the DANSyl- 
gangliosidoi’de took place into the lipid bilayer of the 
membrane. In vitro addition of the cholera toxin- 
subunit protein I to DANSyl-gangliosidoi’de leads to 
the formation of a precipitate. At the lymphocyte 
surface membrane this interaction results in a redis- 
tribution of the fluorescent lipid with formation of 
caps. This shows that the incorporated DANSyl- 
gangliosidoi’de is mobile laterally in the plane of the 
surface membrane. The ligand-induced mobility is 
dependent on the temperature. It is also sensitive to 
colchicine, a fact already shown for membrane 
gangliosides by indirect methods [lo]. However, in 
contrast to the results with indirect methods [ 121, 
ligand-induced mobility of DANSyl-gangliosidoi’de 
is influenced by trypsin pretreatment. Moreover, 
DANSyl-gangliosidoi’de-cholera toxin-protein I com- 
plexes redistribute into the same cap as the lympho- 
cyte anti-immunoglobulin receptors. These findings 
strongly suggest he possibility that lipids do not 
move independently but are influenced by or 
comigrate with other membrane components. 
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